Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external video platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name Youtube
Purpose External media

The structure of the scientific program will be mechanism- and process-oriented and will focus on three major tumor entities:

Topic 1: Joint Action on Tumors of the Digestive System
Topic 2: Joint Action on Brain Tumors
Topic 3: Joint Action on Hematological Malignancies

Tumor initiation and progression will not only be investigated from a cancer cell centric view but also include microenvironmental cues such as angiogenesis, inflammation and fibroblastic response. Cross-entity comparison will uncover common targetable nodes within the three tumor entities and their individual subtypes.

The three research topics are structured into 10 work packages giving the PCCC consortium the following overall thematic and structural organization:

© dkfz.de

Topic 1: Joint Action on Tumors of the Digestive System

WP 1: Oncogenic Pathways in Tumor Initiation, Progression and Treatment Resistance
WP 2: Tumor Cell Extravasation and Metastasis
WP 3: Stroma and Tumor Microenvironment
WP 4: Preclinical Discovery and Validation Platform

Topic 2: Joint Action on Brain Tumors

WP 5: Preclinical Studies and Somatic Gene Transfer-based Mouse Models for Childhood Brain Tumors
WP 6: Advanced Mouse Models for Glioblastoma multiforme

Topic 3: Joint Action on Hematological Malignancies

WP 7: Preclinical Models for AML and ALL
WP 8: Preclinical Mouse Models for B and T Cell Lymphoma
WP 9: Synthetic Lethality Approaches for Personalized Treatment
WP 10: Generation of a Collaborative Platform between the Consortium and Major Clinical Leukemia and Lymphoma Study Groups

to top
powered by webEdition CMS